Dehydrodolichyl diphosphate synthase (DHDDS) and Nogo-B receptor (NgBR) form the heteromeric human cis-prenyltransferase complex, synthesizing the precursor for the glycosyl carrier involved in N-linked protein glycosylation. In line with the important role of N-glycosylation in protein biogenesis, mutations in DHDDS, the catalytic subunit of the complex, were shown to result in human diseases. Importantly, well-characterized DHDDS homologs function as homodimers and not as heteromeric complexes. Moreover, DHDDS encompasses a C-terminal region, which does not converge with any known conserved domains. Therefore, despite the clinical importance of DHDDS, our understating of its structure-function relations remains poor. Here, we provide a structural model for the full-length human DHDDS using a multidisciplinary experimental and computational approach. Our model suggests that the C-terminal domain of DHDDS forms a helix-loop-helix motif, tightly packed against the core catalytic cis-prenyltransferase domain. This model is consistent with small-angle X-ray scattering data, indicating that the full-length DHDDS maintains a similar conformation in solution. Moreover, hydrogen-deuterium exchange mass-spectrometry experiments show time-dependent deuterium uptake in the C-terminal domain, consistent with its overall folded state. Finally, we provide a model for the DHDDS-NgBR heterodimer, offering a structural framework for future structural and functional studies of the human cis-prenyltransferase complex.Keywords: cis-prenyltransferase, computational modelling, hydrogen-deuterium exchange mass-spectrometry, small-angle X-ray scattering, enzyme kinetics, DHDDS
IntroductionProtein N-glycosylation is a critical post-translational modification, in which an oligosaccharide moiety is transferred from the glycosyl carrier dolichol-phosphate (Dol-P) and covalently attaches to a polypeptide chain via an asparagine residue [1]. Following protein conjugation, the oligosaccharide is further modified, increasing the functional and structural diversity of the proteome [2]. Indeed, this modification is crucial for proper protein folding, oligomerization, quality control, sorting, and transport [2]. Accordingly, even slight variations in protein glycosylation can markedly affect proteins structure and function [3] and thus, glycosylation disorders result in a wide range of clinical syndromes affecting practically every organ system [4,5].Dehydrodolichyl diphosphate synthase (DHDDS) together with Nogo-B receptor (NgBR) form the human cis-prenyltransferase complex [6,7]. This complex catalyzes the formation of dehydrodolichyl diphosphate (DHDD), a long-chain polyprenyl serving as a precursor for Dol-P. DHDD is synthesized by chain elongation of farnesyl diphosphate (FPP) via multiple condensations with isopentenyl diphosphate (IPP) ( Figure 1A) [6]. Importantly, while previous studies revealed that DHDDS is required and sufficient for this catalytic activity, NgBR induces an increase in the expression and activity of the complex but ex...